59 results
Page 2 of 3
S-3
cf9y7tfa6bz7
4 Feb 22
Shelf registration
4:36pm
8-K
EX-99.1
vlu56v
5 Jan 22
InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook
2:22pm
8-K
EX-99.1
w35q9svzyq
10 Nov 21
InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
1:08pm
8-K
EX-99.1
n4i40s
3 Nov 21
Other Events
2:00pm
DEF 14A
a6rdbw 8rihdekk4i
28 Oct 21
Definitive proxy
3:07pm
8-K
EX-2.1
0x0v1e1n
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
EX-2.1
ifajiketrs9 yn
24 Sep 21
Annual report
7:31am
424B3
lp5 141rh
22 Jul 21
Prospectus supplement
10:27am
424B3
ji2f502 b2
16 Mar 21
Prospectus supplement
12:00am
8-K
EX-99.1
t8mn9
20 Jan 21
Regulation FD Disclosure
3:43pm
8-K
EX-99.1
97hlec2ut
19 Jan 21
Regulation FD Disclosure
2:42pm
424B4
8ty 3t8io
13 Nov 20
Prospectus supplement with pricing info
8:52pm
S-1
EX-10.7
0mfrw
19 Jun 20
IPO registration
4:59pm
S-1
qpudrjozc qiim
19 Jun 20
IPO registration
4:59pm